RIPK3 and neoplasm: Necroptosis is a novel form of programmed cell death distinct from apoptosis that enhances CD8+ T cell-mediated anti-tumor immunity via a mechanism involving RIPK3 and RIPK1 activation in the tumor microenvironment (TME) [8].